Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sugammadex Versus Neostigmine in Pediatric Day-case Cancer Surgery

NCT03996655 is registered in ClinicalTrials.gov with National Cancer Institute, Egypt as lead sponsor.

NCT NCT03996655
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03996655 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sugammadex Versus Neostigmine in Pediatric Day-case Cancer Surgery
Lead sponsor
National Cancer Institute, Egypt
Phase
Phase 4
Overall status
Unknown status
Start date
June 30, 2019
Completion date
October 31, 2019
Enrollment
80 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

post-operative residual curarization